Fresenius Kabi launches Levothyroxine Sodium Injection Solution in US
German pharma company Fresenius Kabi has launched its severe hypothyroidism treatment -Levothyroxine Sodium Injection Solution in 100 mcg per 5 mL, 200 mcg per 5 ... Read More
Fresenius Kabi launches Methocarbamol Injection in US for acute musculoskeletal conditions
Fresenius Kabi, the global German healthcare company, has unveiled Methocarbamol Injection, USP in the United States, marking a significant expansion of its anesthesia and analgesia ... Read More
Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options
German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide Injection. This product, a generic version of ... Read More